Biotest
Ute Sicker is a seasoned professional with extensive experience in stability studies and dossier management, currently holding the position of Manager Stability Studies/Dossier at Biotest AG since March 2017. Prior to this role, Ute Sicker worked at Paul-Ehrlich-Institut from October 1998 to September 2016 as a Wissenschaftlicher Mitarbeiter, focusing on microbiological assessments related to approval and registration procedures for gene therapies, ATMPs, blood, and stem cells, as well as projects concerning the bacteriological safety of blood components. Early in the career, Ute Sicker served as a Biologisch-technische Assistentin at Umwelt Bundesamt between October 1990 and October 1992, specializing in ICP AES and GC. Ute Sicker holds a Dipl. oec. troph. degree in Oecotrophologie from Justus Liebig University Giessen and a degree in Ökologie und Umweltschutz from Rheinische Akademie Köln.
This person is not in the org chart
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.